Evoke Pharma, Inc. (EVOK) Stock Overview
Explore Evoke Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Evoke Pharma, Inc. (EVOK)
Key Financials
Key Financials
Market Cap
18.9M
P/E Ratio
-5.38
EPS (TTM)
$-1.38
ROE
-1.01%
EVOK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Evoke Pharma, Inc. (EVOK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.38 and a market capitalization of 18.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.